Webinars on demand

If you are curious about world health initiatives or taking mentorship further afield – this is the webinar for you. Dr Cooper will share his experience of creating pathology partnerships, teaching in low-resource settings, and the mutual benefits of outreach projects

In this webinar, Dr. Susan Crocker will share her findings from several samples analyzed with OGM and VIA™ software, shedding light on how this innovative cytogenetic approach is revolutionizing her clinical research laboratory.

Are you starting to scale up your pathology department’s digitisation efforts? This panel discussion will explore the different options available to labs for digital pathology image lifecycle management, including the ability to leverage already existing infrastructure in hospitals in the form of vendor neutral archives.

We are delighted to welcome you to this webinar, sponsored by Exact Sciences*, about the changing role of pathologists in the area of precision oncology.

The goal of this webinar is to share the learnings around the ease of onboarding a liquid biopsy solution in a laboratory setting

In this webinar, Dr. Jantus-Lewintre shares her lab's experience evaluating the Oncomine Comprehensive Assay Plus

In their retrospective study Integra Connect investigated how this behavior affects outcomes.

In this Bionano in Motion webinar, we explore the utility and validity of an innovative strategy, proposed by Dr Brandes from Heinrich-Heine University and University Hospital Dusseldorf that combines Optical Genome Mapping (OGM) and whole exome sequencing (WES) in 60 HD and ETV6::RUNX1+ BCP-ALL cases. This study shows that OGM detected a high number of additional SVs not identified using the conventional methods, including (subclonal) IKZF1 deletions, a prognostically relevant subtype.

In this Bionano in Motion webinar, we explore the utility and validity of an innovative strategy, proposed by Dr. Kolhe’s lab, from Augusta University, that combines optical genome mapping (OGM) with a comprehensive 523-gene next-generation sequencing (NGS) panel. This unique approach was meticulously evaluated against more traditional methods including karyotyping, fluorescent in situ hybridization (FISH), and a 54-gene NGS panel.

We are thrilled to invite you to our upcoming online webinar, where we will delve into groundbreaking research on the spatial organization of immune cells in human tumors and its impact on immunotherapy outcomes.

In this webinar, Dr Federico Cappuzzo will speak about clinical implications of liquid biopsy-based CGP for lung cancer patients, discussing current clinical evidence and sharing his vision on future applications.

Join Illumina and Parse Biosciences for a webinar where our invited speaker will present results of his recent single-cell study.